Increased expression of triggering receptor expressed on myeloid cells-1 in the population with obesity and insulin resistance

Saravanan Subramanian, Pradeep K. Pallati, Vikrant Rai, Poonam K Sharma, Devendra K. Agrawal, Kalyana C. Nandipati

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective: Triggering receptor expressed on myeloid cells (TREM)−1 has recently been recognized as one of the potent amplifiers of acute and chronic inflammation. However, the exact role of TREM-1 in regard to insulin insensitivity is unknown. Methods: mRNA transcripts and protein expression of TREM-1, TREM-2, and TREM-1/TREM-2 ratio were examined in the tissue biopsies (liver, omentum, and subcutaneous fat) and blood samples (neutrophils and monocytes) of subjects with obesity and diabetes (SO+ D+; n = 15), subjects with obesity but not diabetes (SO+ D; n = 7), and subjects without obesity (BMI < 30) and diabetes (SOD; n = 5). Results: The immunofluorescence and RT-PCR revealed significant increase in TREM-1, decrease in TREM-2, and increase in the TREM1/TREM2 ratio in SO+ D+ group compared with other groups. Overall, increased liver TREM-1 expression and soluble-TREM-1 were found in SO+ D+ group compared with SO+ D group (100% vs. 57.14%, r = 0.582; P = 0.023). TREM-1 was significantly increased in all subjects with obesity and those with HOMA-IR index of >2. Conclusions: TREM-1 was found to be significantly higher in tissues biopsies and blood of subjects with obesity. Greater expression and activity of TREM-1 suggest a possible role in the underlying pathophysiology of obesity and associated comorbidities.

Original languageEnglish (US)
Pages (from-to)527-538
Number of pages12
JournalObesity
Volume25
Issue number3
DOIs
StatePublished - Mar 1 2017

Fingerprint

Myeloid Cells
Insulin Resistance
Obesity
Population
Biopsy
Omentum
Subcutaneous Fat
Comorbidity
Monocytes
Neutrophils
Insulin
Inflammation
Messenger RNA
Liver

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Nutrition and Dietetics

Cite this

Increased expression of triggering receptor expressed on myeloid cells-1 in the population with obesity and insulin resistance. / Subramanian, Saravanan; Pallati, Pradeep K.; Rai, Vikrant; Sharma, Poonam K; Agrawal, Devendra K.; Nandipati, Kalyana C.

In: Obesity, Vol. 25, No. 3, 01.03.2017, p. 527-538.

Research output: Contribution to journalArticle

@article{27fe7e1a70ef43e6ae2c728a81d3fb39,
title = "Increased expression of triggering receptor expressed on myeloid cells-1 in the population with obesity and insulin resistance",
abstract = "Objective: Triggering receptor expressed on myeloid cells (TREM)−1 has recently been recognized as one of the potent amplifiers of acute and chronic inflammation. However, the exact role of TREM-1 in regard to insulin insensitivity is unknown. Methods: mRNA transcripts and protein expression of TREM-1, TREM-2, and TREM-1/TREM-2 ratio were examined in the tissue biopsies (liver, omentum, and subcutaneous fat) and blood samples (neutrophils and monocytes) of subjects with obesity and diabetes (SO+ D+; n = 15), subjects with obesity but not diabetes (SO+ D−; n = 7), and subjects without obesity (BMI < 30) and diabetes (SO−D−; n = 5). Results: The immunofluorescence and RT-PCR revealed significant increase in TREM-1, decrease in TREM-2, and increase in the TREM1/TREM2 ratio in SO+ D+ group compared with other groups. Overall, increased liver TREM-1 expression and soluble-TREM-1 were found in SO+ D+ group compared with SO+ D− group (100{\%} vs. 57.14{\%}, r = 0.582; P = 0.023). TREM-1 was significantly increased in all subjects with obesity and those with HOMA-IR index of >2. Conclusions: TREM-1 was found to be significantly higher in tissues biopsies and blood of subjects with obesity. Greater expression and activity of TREM-1 suggest a possible role in the underlying pathophysiology of obesity and associated comorbidities.",
author = "Saravanan Subramanian and Pallati, {Pradeep K.} and Vikrant Rai and Sharma, {Poonam K} and Agrawal, {Devendra K.} and Nandipati, {Kalyana C.}",
year = "2017",
month = "3",
day = "1",
doi = "10.1002/oby.21714",
language = "English (US)",
volume = "25",
pages = "527--538",
journal = "Obesity",
issn = "1930-7381",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Increased expression of triggering receptor expressed on myeloid cells-1 in the population with obesity and insulin resistance

AU - Subramanian, Saravanan

AU - Pallati, Pradeep K.

AU - Rai, Vikrant

AU - Sharma, Poonam K

AU - Agrawal, Devendra K.

AU - Nandipati, Kalyana C.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Objective: Triggering receptor expressed on myeloid cells (TREM)−1 has recently been recognized as one of the potent amplifiers of acute and chronic inflammation. However, the exact role of TREM-1 in regard to insulin insensitivity is unknown. Methods: mRNA transcripts and protein expression of TREM-1, TREM-2, and TREM-1/TREM-2 ratio were examined in the tissue biopsies (liver, omentum, and subcutaneous fat) and blood samples (neutrophils and monocytes) of subjects with obesity and diabetes (SO+ D+; n = 15), subjects with obesity but not diabetes (SO+ D−; n = 7), and subjects without obesity (BMI < 30) and diabetes (SO−D−; n = 5). Results: The immunofluorescence and RT-PCR revealed significant increase in TREM-1, decrease in TREM-2, and increase in the TREM1/TREM2 ratio in SO+ D+ group compared with other groups. Overall, increased liver TREM-1 expression and soluble-TREM-1 were found in SO+ D+ group compared with SO+ D− group (100% vs. 57.14%, r = 0.582; P = 0.023). TREM-1 was significantly increased in all subjects with obesity and those with HOMA-IR index of >2. Conclusions: TREM-1 was found to be significantly higher in tissues biopsies and blood of subjects with obesity. Greater expression and activity of TREM-1 suggest a possible role in the underlying pathophysiology of obesity and associated comorbidities.

AB - Objective: Triggering receptor expressed on myeloid cells (TREM)−1 has recently been recognized as one of the potent amplifiers of acute and chronic inflammation. However, the exact role of TREM-1 in regard to insulin insensitivity is unknown. Methods: mRNA transcripts and protein expression of TREM-1, TREM-2, and TREM-1/TREM-2 ratio were examined in the tissue biopsies (liver, omentum, and subcutaneous fat) and blood samples (neutrophils and monocytes) of subjects with obesity and diabetes (SO+ D+; n = 15), subjects with obesity but not diabetes (SO+ D−; n = 7), and subjects without obesity (BMI < 30) and diabetes (SO−D−; n = 5). Results: The immunofluorescence and RT-PCR revealed significant increase in TREM-1, decrease in TREM-2, and increase in the TREM1/TREM2 ratio in SO+ D+ group compared with other groups. Overall, increased liver TREM-1 expression and soluble-TREM-1 were found in SO+ D+ group compared with SO+ D− group (100% vs. 57.14%, r = 0.582; P = 0.023). TREM-1 was significantly increased in all subjects with obesity and those with HOMA-IR index of >2. Conclusions: TREM-1 was found to be significantly higher in tissues biopsies and blood of subjects with obesity. Greater expression and activity of TREM-1 suggest a possible role in the underlying pathophysiology of obesity and associated comorbidities.

UR - http://www.scopus.com/inward/record.url?scp=85013361047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013361047&partnerID=8YFLogxK

U2 - 10.1002/oby.21714

DO - 10.1002/oby.21714

M3 - Article

VL - 25

SP - 527

EP - 538

JO - Obesity

JF - Obesity

SN - 1930-7381

IS - 3

ER -